Gluskin Sheff & Assoc Inc Albemarle Corp Transaction History

Gluskin Sheff & Assoc Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$72.69 - $92.28 $1.45 Million - $1.84 Million	-19,990 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$73.13 - $107.99 $569,682 - $841,242	-7,790 Reduced 28.04%	19,990 $1.54 Million
Q3 2018 Nov 09, 2018	SELL	$90.9 - $106.6 $93,627 - $109,798	-1,030 Reduced 3.58%	27,780 $2.77 Million
Q2 2018 Aug 13, 2018	BUY	$88.96 - $104.92 $1.13 Million - $1.33 Million	12,690 Added 78.72%	28,810 $2.72 Million
Q1 2018 May 14, 2018	BUY	$89.56 - $137.45 $1.44 Million - $2.22 Million	16,120 New	16,120 $1.5 Million

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.